CAS 558447-26-0

AMD 070

CAS: 558447-26-0

Formel: C₂₁H₂₇N₅

Reinheit: %

Farbe und Form: Solid

Molekulargewicht: 349.4726

Ref: IN-DA00DB4P

Mavorixafor

CAS: 558447-26-0

Mavorixafor

Reinheit: ≥98%

Molekulargewicht: 349.47g/mol

Ref: 54-BUP04495

(S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine

CAS: 558447-26-0

(S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine is an activated molecule that has been shown to be effective in the treatment of chronic kidney disease. This molecule is a monoclonal antibody that binds to CCR5 and blocks HIV from entering the cell. In addition, this drug has shown activity against hepatitis B and chemokines. The pharmacodynamics of (S)-N1-(5,6,7,8 tetrahydroquinolin-8-yl)butane-1,4 diamine are not well understood because it is administered intravenously as a bolus dose. However, this molecule may have an effect on the immune system by suppressing myeloid derived suppressor cells or maculopapular skin reactions.

Formel: C₂₁H₂₇N₅

Reinheit: Min. 95 Area-%

Farbe und Form: Powder

Molekulargewicht: 349.48 g/mol

Ref: 3D-IXA44726

Mavorixafor

CAS: 558447-26-0

Mavorixafor (AMD-070) is an effective and selective antagonist of CXCR4, with an IC50 value of 13 nM against CXCR4 125I-SDF binding.

Formel: C₂₁H₂₇N₅

Reinheit: 98.56%

Farbe und Form: Solid

Molekulargewicht: 349.47

Ref: TM-TQ0174